Sandstone Diagnostics operates in the healthcare diagnostics market, specializing in point-of-care (POC) clinical diagnostics. The company’s core technology, Torq, is a portable centrifuge system designed to bring sample preparation directly to the patient, thereby improving the quality, stability, and yield of blood plasma or serum samples. This innovation is particularly valuable for decentralized and remote healthcare settings, where traditional lab infrastructure may be lacking. Sandstone serves a diverse range of clients including healthcare providers, telehealth services, and research institutions. The company has formed strategic partnerships with organizations like Myriad Genetics and Beacon Biomedical to enhance early cancer screening and liquid biopsy sample quality. Sandstone’s business model revolves around the sale and distribution of its proprietary diagnostic devices and related consumables. Revenue is generated through direct sales, partnerships, and potentially through government contracts, as evidenced by their inclusion in the GSA Schedule. The company is also actively involved in research and development, continuously expanding its technology pipeline to address emerging healthcare needs.

Keywords: point-of-care, diagnostics, centrifuge, blood sampling, telehealth, decentralized healthcare, sample quality, liquid biopsy, early cancer screening, healthcare innovation.